Transparent Thinking Blog

FORMER GILEAD SCIENCES HEAD OF CLINICAL TRIAL…

by Donald McLean, MBA,
Posted on 4/16/2020

CANTON, Mich. (April 16, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today the addition of Kelly Vaillant as Director, Global Transparency Strategy and Compliance.…
Read More
Think201